Clinical Trial Update: Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection
• Surgical Site Infection

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Late Effects of Surgery, Staphylococcus Aureus | Phase 3 | Status: COMPLETED | Results posted: 2016-08-29